Close Menu

This article has been updated with the names of the partners providing funding.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canada's Prevention of Organ Failure (PROOF) Centre of Excellence in Vancouver will use C$1.5 million (US$1.5 million) in new funding to develop a biomarker-based test for determining a person's risk for having a lung attack.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.